2023
DOI: 10.1111/jocd.15962
|View full text |Cite
|
Sign up to set email alerts
|

Treating rosacea with botulism toxin: Protocol for a systematic review and meta‐analysis

Guanjin He,
Qifeng Yang,
Jin Wu
et al.

Abstract: BackgroundRosacea is a chronic inflammatory disease usually associated with persistent erythema and periodic flushing. This disease is difficult to treat, and the outcomes are often unsatisfactory and prone to recurrence. In recent years, botulinum toxin has been used as a new treatment for rosacea; however, its efficacy and safety remain under discussion. Although a systematic review of the effectiveness and safety of botulinum toxin has been previously conducted by other researchers, our systematic review an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 42 publications
(65 reference statements)
0
2
0
Order By: Relevance
“…Of note, He at al. 28 recently published a meta-analysis on the use of botulinum toxin in treating erythema associated with rosacea. Their findings also demonstrated a significant reduction in flushing scores 1 month after toxin injection.…”
Section: Discussionmentioning
confidence: 99%
“…Of note, He at al. 28 recently published a meta-analysis on the use of botulinum toxin in treating erythema associated with rosacea. Their findings also demonstrated a significant reduction in flushing scores 1 month after toxin injection.…”
Section: Discussionmentioning
confidence: 99%
“…1 This drug has several applications in medicine, both for therapeutic and cosmetic use. Those applications include treatment for hyperhidrosis, 2 strabismus, 3 acne, 4 rosacea, 5 open pores, 6 scars, 7 and many other conditions. Despite the benefits associated with those procedures, they may carry a risk of adverse effects, which can be local or systemic, depending on the dose, brand of neurotoxin, route of administration, and injection technique.…”
mentioning
confidence: 99%
“…Zhang et al 4 tried to perform a meta-analysis on previous data existed in the literature in this regard, but could not reach to a conclusive result due to the heterogeneity of studies. However, a very recent systematic review and meta-analysis by He et al 16 evaluated the results of 22 studies, involving 720 subjects and reported significant and long-term improvement in patient signs and symptoms.…”
mentioning
confidence: 99%